In summary, AFP interferes with the cascade conduction of the RA‐RAR signalling pathway by regulating the transcription factor RAR, thus reducing the sensitivity of hepatoma cells to the chemotherapy drug ATRA. Here, AFP is linked to hepatocellular carcinoma.